The suppression of involuntary movements with tetrabenazine.

Suppr

超能文献

作者信息

McLellan D L

出版信息

Scott Med J. 1972 Nov;17(11):367-70. doi: 10.1177/003693307201701105.

DOI:10.1177/003693307201701105

PMID:4264428

Abstract

摘要

相似文献

The suppression of involuntary movements with tetrabenazine.

Scott Med J. 1972 Nov;17(11):367-70. doi: 10.1177/003693307201701105.

Treatment of involuntary movement disorders with tetrabenazine.

J Neurol Neurosurg Psychiatry. 1972 Apr;35(2):186-91. doi: 10.1136/jnnp.35.2.186.

Tetrabenazine in the treatment of extrapyramidal dyskinesias.

Med J Aust. 1972 Nov 4;2(19):1054-6. doi: 10.5694/j.1326-5377.1972.tb103717.x.

Effect of tetrabenazine on extrapyramidal movement disorders.

Br Med J. 1969 May 17;2(5654):422-3. doi: 10.1136/bmj.2.5654.422.

Tetrabenazine for involuntary movement disorders.

Med J Aust. 1979 Jun 30;1(13):628-30. doi: 10.5694/j.1326-5377.1979.tb119426.x.

Tetrabenazine and movement disorders.

Neurology. 1981 Aug;31(8):1051-4. doi: 10.1212/wnl.31.8.1051.

Tetrabenazine in the treatment of hyperkinetic movement disorders.

Expert Rev Neurother. 2006 Jan;6(1):7-17. doi: 10.1586/14737175.6.1.7.

Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.

Am J Geriatr Pharmacother. 2010 Aug;8(4):331-73. doi: 10.1016/j.amjopharm.2010.08.006.

Drug treatment of diseases characterized by abnormal movements.

Proc R Soc Med. 1973 Sep;66(9):871-3. doi: 10.1177/003591577306600920.

Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both.

Arch Neurol. 1974 Nov;31(5):352-3. doi: 10.1001/archneur.1974.00490410100014.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The suppression of involuntary movements with tetrabenazine.

Scott Med J. 1972 Nov;17(11):367-70. doi: 10.1177/003693307201701105.

Treatment of involuntary movement disorders with tetrabenazine.

J Neurol Neurosurg Psychiatry. 1972 Apr;35(2):186-91. doi: 10.1136/jnnp.35.2.186.

Tetrabenazine in the treatment of extrapyramidal dyskinesias.

Med J Aust. 1972 Nov 4;2(19):1054-6. doi: 10.5694/j.1326-5377.1972.tb103717.x.

Effect of tetrabenazine on extrapyramidal movement disorders.

Br Med J. 1969 May 17;2(5654):422-3. doi: 10.1136/bmj.2.5654.422.

Tetrabenazine for involuntary movement disorders.

Med J Aust. 1979 Jun 30;1(13):628-30. doi: 10.5694/j.1326-5377.1979.tb119426.x.

Tetrabenazine and movement disorders.

Neurology. 1981 Aug;31(8):1051-4. doi: 10.1212/wnl.31.8.1051.

Tetrabenazine in the treatment of hyperkinetic movement disorders.

Expert Rev Neurother. 2006 Jan;6(1):7-17. doi: 10.1586/14737175.6.1.7.

Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.

Am J Geriatr Pharmacother. 2010 Aug;8(4):331-73. doi: 10.1016/j.amjopharm.2010.08.006.

Drug treatment of diseases characterized by abnormal movements.

Proc R Soc Med. 1973 Sep;66(9):871-3. doi: 10.1177/003591577306600920.

Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both.

Arch Neurol. 1974 Nov;31(5):352-3. doi: 10.1001/archneur.1974.00490410100014.